NCT02217865

Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer

Completed Last updated 15 February 2022

What this trial tests

trial testing Interviews - Colorectal Cancer Participants in Colorectal Cancer in 32 participants. Completed in 13 January 2022.

Timeline

16 July 2014

Primary endpoint
13 January 2022

13 January 2022

Quick facts

Lead sponsor	M.D. Anderson Cancer Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	32
Start date	16 July 2014
Primary completion	13 January 2022
Estimated completion	13 January 2022
Sites	3 locations across United States

Drugs / interventions tested

• Interviews - Colorectal Cancer Participants
• Questionnaire
• Focus Groups
• Interviews - Caregivers of Colorectal Cancer Participants

Conditions studied

• Colorectal Cancer — all drugs for Colorectal Cancer →

Sponsor

M.D. Anderson Cancer Center — full company profile →

Who can join

21 and older, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The long-term goal of this research is to develop new tools to guide patients, caregivers, and clinicians in making individualized decisions regarding colorectal cancer (CRC) surveillance. As part of a Patient-Centered Outcomes Research Institute-funded contract, investigator will analyze surveillance data to determine the effectiveness of CRC surveillance and recurrence risk taking into account different patient and tumor characteristics; identify key issues about CRC surveillance important to patients, caregivers, and clinicians; and integrate the recurrence risk and patient priorities into a patient-centered, risk stratified surveillance strategy by creating an interactive decision aid for use by patients and clinicians.

This protocol addresses a formative step in the creation of the interactive decision aid where patients' information needs and preferences are assessed regarding decisions about surveillance.

The specific aims of this protocol are:

Phase 1 - To interview patients and their caregivers to determine their concerns, preferences and key priorities regarding surveillance after curative resection of colorectal cancer, and

Phase 2 - To refine the key priorities identified in phase 1 through focus groups and surveys with patients and caregivers.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

1. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
   Snyder RA, Hu CY, Cuddy A, Francescatti AB, et al · · 2018 · cited 89× · PMID 29800181 · DOI 10.1001/jama.2018.5816
2. Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study.
   Zafar SN, Hu CY, Snyder RA, Cuddy A, et al · · 2020 · cited 33× · PMID 32080809 · DOI 10.1245/s10434-020-08238-7
3. Evaluating Surveillance Patterns after Chemoradiation-Only Compared with Conventional Management for Older Patients with Rectal Cancer.
   Ellis CT, Cole AL, Sanoff HK, Hinton S, et al · · 2019 · cited 1× · PMID 30685478 · DOI 10.1016/j.jamcollsurg.2019.01.010